🔎 Trials Near Me

Home › Sakit ni Alzheimer › Texas › Dallas

Pag-aaral pangklinika para sa Sakit ni Alzheimer sa Dallas, TX

Isang pag-aaral para sa Sakit ni Alzheimer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

Nagre-recruitPhase 2
  • Kerwin Medical Center- Site Number : 8400006, Dallas
Edad 55 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07688213

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Nagre-recruitPhase 3
  • Local Institution - 1260, Dallas
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06585787

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Nagre-recruitPhase 2
  • Kerwin Medical Center, Dallas
Edad 55 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589595

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Nagre-recruitPhase 2
  • Kerwin Research Center, LLC - Oak Cliff, Dallas
  • Kerwin Research Center, LLC in Texas, Dallas
Edad 55 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Nagre-recruitPhase 3
  • Kerwin Medical Center, Dallas
  • Kerwin Research Center, LLC, Dallas
Edad 50 hanggang 90 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07177352

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

Nagre-recruitPhase 1/2
  • Kerwin Medical Center /ID# 277788, Dallas
Edad 50 hanggang 90 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07599670

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Nagre-recruitPhase 3
  • Local Institution - 0081, Dallas
Edad 60 hanggang 85 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06976203

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Nagre-recruitPhase 3
  • University of Texas Southwestern, Dallas
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Nagre-recruitPhase 2/3Malugod na tinatanggap ang malusog na boluntaryo
  • Kerwin Research and Memory Center, Dallas
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Nagre-recruitPhase 2/3Malugod na tinatanggap ang malusog na boluntaryo
  • Kerwin Research and Memory Center, Dallas
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT06647498

[18F]PI-2620 Phase 3 Histopathological Study

Nagre-recruitPhase 3
  • Baylor Research Institute, Dallas
Edad 50 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05641688

Late Onset Alzheimer's Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • University of Texas Southwestern, Dallas
Edad 55 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT05010603

Pag-aaral para sa Sakit ni Alzheimer sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.